These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 2383892
1. In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats. Felgar RE, Hiserodt JC. Cell Immunol; 1990 Sep; 129(2):288-98. PubMed ID: 2383892 [Abstract] [Full Text] [Related]
2. Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer. Basse PH. APMIS Suppl; 1995 Sep; 55():1-28. PubMed ID: 8534522 [Abstract] [Full Text] [Related]
3. Adoptive immunotherapy using lymphokine-activated killer cells and recombinant interleukin-2 in preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor. Tjota A, Zhang YQ, Piedmonte MR, Lee CL. J Urol; 1991 Jul; 146(1):177-83. PubMed ID: 2056587 [Abstract] [Full Text] [Related]
4. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Schwarz RE, Vujanovic NL, Hiserodt JC. Cancer Res; 1989 Mar 15; 49(6):1441-6. PubMed ID: 2784350 [Abstract] [Full Text] [Related]
5. Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals. Kjaergaard J, Hokland ME, Agger R, Skovbo A, Nannmark U, Basse PH. Cancer Immunol Immunother; 2000 Jan 15; 48(10):550-60. PubMed ID: 10630307 [Abstract] [Full Text] [Related]
6. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. Mulé JJ, Yang J, Shu S, Rosenberg SA. J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106 [Abstract] [Full Text] [Related]
15. Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion. Kuppen PJ, Marinelli A, Camps JA, Pauwels EK, van de Velde CJ, Fleuren GJ, Eggermont AM. Int J Cancer; 1992 Sep 09; 52(2):266-70. PubMed ID: 1521913 [Abstract] [Full Text] [Related]
16. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells. Holladay FP, Heitz T, Wood GW. J Neurosurg; 1992 Nov 09; 77(5):757-62. PubMed ID: 1403119 [Abstract] [Full Text] [Related]